• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种族特异性参考范围会影响四联检测在发展中国家作为唐氏综合征通用筛查的效果。

Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University Hat Yai, Hat Yai, Songkhla, Thailand.

出版信息

PLoS One. 2021 May 13;16(5):e0251381. doi: 10.1371/journal.pone.0251381. eCollection 2021.

DOI:10.1371/journal.pone.0251381
PMID:33984018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8118253/
Abstract

OBJECTIVE

To evaluate the efficacy of the quadruple test for potential use as a Thai national policy for Down syndrome (DS) screening and establish an accurate equation for risk estimation of Down syndrome based on gestational age, weight and the ethnic-specific reference range of our population.

METHODS

A prospective study was conducted on singleton pregnancies at 14 to 21 weeks of gestation to evaluate the efficacy of quadruple DS screening using the automatically calculated Western European descent factor (WF) in our population and the impact of screening using a specific Thai ethnic factor as well as to establish an equation for the risk estimation of DS based on gestational age, weight and a local Thai ethnic factor to correct for the impact of ethnic factor on the screening efficacy.

RESULTS

Of a total of 5,515 women, 12 cases of DS and 8 cases of other aneuploidies were found. The detection rate, false positive rate and specificity were 75.0%, 9.1% and 90.9%, respectively, by automatic calculation with the widely used WF; the screening efficacy was lower when used in Asian populations than in other studies. The best-fitted regression equation of serum quadruple screening of AFP, free β-hCG, uE3 and inhibin A was established by adjustment for gestational age (GA) in days, maternal weight and our Thai-specific ethnic reference range which was created for this study. Calculations with our Thai-specific ethnic model gave a better detection rate of 83.3%, a false positive rate of 9.6% and specificity of 90.4%.

CONCLUSION

The serum quadruple test had a lower detection rate than expected when the risk estimation was based on the WF reference range. The serum quadruple test using WF had significantly different levels when corrected with our ethnic-specific factor. Using our local ethnic specific model could increase the detection rate of DS screening in Thailand with a minimal increase in false positive rates. Our findings indicate that DS screening should be adjusted with an appropriate individual ethnic factor when used for national screening.

摘要

目的

评估四联试验在唐氏综合征(DS)筛查中的应用效果,建立适合泰国人群的基于年龄、体重和特定种族参考范围的 DS 风险估算方程。

方法

对 14-21 孕周的单胎妊娠进行前瞻性研究,评估在本人群中使用自动计算的西方欧洲血统因子(WF)进行四联 DS 筛查的效果,以及使用特定的泰国种族因子进行筛查的效果,并建立基于年龄、体重和本地泰国种族因子的 DS 风险估算方程,以校正种族因子对筛查效果的影响。

结果

共 5515 名女性中,发现 12 例 DS 和 8 例其他非整倍体。自动计算广泛使用的 WF 时,检出率、假阳性率和特异性分别为 75.0%、9.1%和 90.9%;在亚洲人群中的筛查效果低于其他研究。通过调整胎龄(GA)天数、母亲体重和本研究创建的泰国特定种族参考范围,建立了 AFP、游离β-hCG、uE3 和抑制素 A 的血清四联筛查最佳拟合回归方程。使用我们泰国特有的种族模型计算得出的检出率为 83.3%、假阳性率为 9.6%、特异性为 90.4%,效果更好。

结论

基于 WF 参考范围进行风险评估时,血清四联试验的检出率低于预期。使用我们特定种族的因子校正后,血清四联试验的 WF 水平有显著差异。使用我们当地的特定种族模型可以在最小增加假阳性率的情况下提高泰国 DS 筛查的检出率。我们的研究结果表明,DS 筛查在用于全国性筛查时应根据适当的个体种族因素进行调整。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/603061ec9d27/pone.0251381.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/ac0f0da75ca8/pone.0251381.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/b122852a5731/pone.0251381.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/538fd2cee5ec/pone.0251381.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/603061ec9d27/pone.0251381.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/ac0f0da75ca8/pone.0251381.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/b122852a5731/pone.0251381.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/538fd2cee5ec/pone.0251381.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e71/8118253/603061ec9d27/pone.0251381.g004.jpg

相似文献

1
Ethnic-specific reference range affects the efficacy of quadruple test as a universal screening for Down syndrome in a developing country.种族特异性参考范围会影响四联检测在发展中国家作为唐氏综合征通用筛查的效果。
PLoS One. 2021 May 13;16(5):e0251381. doi: 10.1371/journal.pone.0251381. eCollection 2021.
2
Effect of allowing for ethnic group in prenatal screening for Down's syndrome.在唐氏综合征产前筛查中考虑种族因素的影响。
Prenat Diagn. 1996 Aug;16(8):691-8. doi: 10.1002/(SICI)1097-0223(199608)16:8<691::AID-PD946>3.0.CO;2-2.
3
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.孕早期和孕中期筛查:除唐氏综合征外的非整倍体检测。
Obstet Gynecol. 2007 Sep;110(3):651-7. doi: 10.1097/01.AOG.0000278570.76392.a6.
4
Different median levels of serum triple markers in the second trimester of pregnancy in a Thai Ethnic Group.泰国某民族妊娠中期血清三联标志物的不同中位数水平。
J Obstet Gynaecol Res. 2012 Apr;38(4):686-91. doi: 10.1111/j.1447-0756.2011.01769.x. Epub 2012 Mar 2.
5
Prospective study of the feasibility and effectiveness of a second-trimester quadruple test for Down syndrome in Thailand.泰国孕中期唐氏综合征四联检测可行性及有效性的前瞻性研究。
Int J Gynaecol Obstet. 2017 Nov;139(2):217-221. doi: 10.1002/ijgo.12290. Epub 2017 Aug 14.
6
First-trimester or second-trimester screening, or both, for Down's syndrome.孕早期或孕中期唐氏综合征筛查,或两者皆做。
N Engl J Med. 2005 Nov 10;353(19):2001-11. doi: 10.1056/NEJMoa043693.
7
[Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].孕中期母体血清三联筛查标志物异常对不良妊娠结局的预测价值
Zhonghua Fu Chan Ke Za Zhi. 2014 Oct;49(10):749-53.
8
Incorporation of inhibin-A in second-trimester screening for Down syndrome.抑制素A在孕中期唐氏综合征筛查中的应用。
Obstet Gynecol. 2003 Mar;101(3):451-4. doi: 10.1016/s0029-7844(02)03159-9.
9
SURUSS in perspective.透视下的SURUSS
Semin Perinatol. 2005 Aug;29(4):225-35. doi: 10.1053/j.semperi.2005.05.006.
10
Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.在亚洲人群中使用甲胎蛋白和游离β-人绒毛膜促性腺激素进行唐氏综合征筛查:台湾唐氏综合征筛查小组报告
Obstet Gynecol. 1996 Jun;87(6):943-7. doi: 10.1016/0029-7844(96)00042-7.

引用本文的文献

1
Effects of Antiseizure Medications on Second-Trimester Prenatal Screening Test Parameters: A Retrospective Cohort Study.抗癫痫药物对孕中期产前筛查测试参数的影响:一项回顾性队列研究。
Medicina (Kaunas). 2025 Jun 17;61(6):1101. doi: 10.3390/medicina61061101.
2
Economic evaluation of prenatal screening for fetal aneuploidies in Thailand.泰国胎儿非整倍体产前筛查的经济评价。
PLoS One. 2023 Sep 15;18(9):e0291622. doi: 10.1371/journal.pone.0291622. eCollection 2023.
3
Performance of Serum Quad Test in Screening for Fetal Down Syndrome in a Large-Scale Unselected Population in a Developing Country.

本文引用的文献

1
Fetal Aneuploidy: Screening and Diagnostic Testing.胎儿非整倍体:筛查和诊断性检测。
Am Fam Physician. 2020 Apr 15;101(8):481-488.
2
Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis.发展中国家的唐氏综合征胎儿筛查模型;第二部分:成本效益分析。
BMC Health Serv Res. 2019 Nov 27;19(1):898. doi: 10.1186/s12913-019-4699-4.
3
Estimating Nationwide Prevalence of Live Births with Down Syndrome and Their Medical Expenditures in Korea.估算韩国唐氏综合征活产儿的全国患病率及其医疗支出。
大规模未选择人群中在发展中国家使用血清四联检测筛查胎儿唐氏综合征的性能。
Int J Public Health. 2023 Apr 5;68:1605441. doi: 10.3389/ijph.2023.1605441. eCollection 2023.
4
Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.泰国一家三级医院的产前筛查检测与胎儿非整倍体的流行率。
PLoS One. 2023 Apr 20;18(4):e0284829. doi: 10.1371/journal.pone.0284829. eCollection 2023.
5
Study on the Effect of B-Ultrasound NT Scan in Early Pregnancy Combined with Serum Screening in Early and Middle Pregnancy for Down Syndrome.早孕期 B 超 NT 扫描联合中孕期血清学筛查对唐氏综合征的效果研究。
Comput Math Methods Med. 2022 Oct 13;2022:7517112. doi: 10.1155/2022/7517112. eCollection 2022.
6
Utility of fetal facial markers on a second trimester genetic sonogram in screening for Down syndrome in a high-risk Thai population.中孕期超声软指标在高危泰国人群唐氏综合征筛查中的应用。
BMC Pregnancy Childbirth. 2022 Jan 11;22(1):27. doi: 10.1186/s12884-021-04332-0.
J Korean Med Sci. 2019 Aug 12;34(31):e207. doi: 10.3346/jkms.2019.34.e207.
4
Out-of-pocket expenditures and care time for children with Down Syndrome: A single-hospital study in Mexico City.唐氏综合征患儿的自付支出和照护时间:墨西哥城单家医院的研究。
PLoS One. 2019 Jan 10;14(1):e0208076. doi: 10.1371/journal.pone.0208076. eCollection 2019.
5
How to correct the impact of ethnicity on effectiveness of the second trimester maternal serum screen of fetal Down syndrome?如何纠正种族因素对孕中期胎儿唐氏综合征母体血清筛查有效性的影响?
J Matern Fetal Neonatal Med. 2019 Oct;32(20):3343-3347. doi: 10.1080/14767058.2018.1463367. Epub 2018 Oct 29.
6
Fewer women aged 35 and older choose serum screening for Down's syndrome: Impact and implications.35 岁及以上的女性选择血清筛查唐氏综合征的人数减少:影响与意义。
J Med Screen. 2019 Jun;26(2):59-66. doi: 10.1177/0969141318797961. Epub 2018 Sep 25.
7
The impact of young maternal age at birth on neonatal mortality: Evidence from 45 low and middle income countries.出生时母亲年龄对新生儿死亡率的影响:来自 45 个低收入和中等收入国家的证据。
PLoS One. 2018 May 23;13(5):e0195731. doi: 10.1371/journal.pone.0195731. eCollection 2018.
8
Down Syndrome Screening in India: Are We There Yet?印度的唐氏综合征筛查:我们做到了吗?
J Obstet Gynaecol India. 2017 Dec;67(6):393-399. doi: 10.1007/s13224-017-1042-z. Epub 2017 Aug 17.
9
Normative weight-adjusted models for the median levels of first trimester serum biomarkers for trisomy 21 screening in a specific ethnicity.特定种族中用于21三体综合征筛查的孕早期血清生物标志物中位数水平的标准化体重校正模型。
PLoS One. 2017 Aug 3;12(8):e0182538. doi: 10.1371/journal.pone.0182538. eCollection 2017.
10
Prospective study of the feasibility and effectiveness of a second-trimester quadruple test for Down syndrome in Thailand.泰国孕中期唐氏综合征四联检测可行性及有效性的前瞻性研究。
Int J Gynaecol Obstet. 2017 Nov;139(2):217-221. doi: 10.1002/ijgo.12290. Epub 2017 Aug 14.